logo

For the Inventor, By the Inventor

Turku, Finland

Biotie Therapies Corporation


USPTO Granted Patents = 28

% Expired Patents = 78.6



Forward Citations = 44

Loading Chart...
Loading Chart...

66 inventors (with patents filed for the assignee):

goldMedal David Smith (10 out of 10 patents)

silverMedal Markku Jalkanen (7 out of 16 patents)

bronzeMedal Thomas R Malefyt (7 out of 21 patents)

4.  Marjo Pihlavisto (7 out of 8 patents)

5.  Zsolt Szakonyi (5 out of 6 patents)

6.  Lesley Pickford (4 out of 4 patents)

7.  Christopher G Salentine (3 out of 11 patents)

8.  Auni Juhakoski (3 out of 3 patents)

9.  Ferenc Fulop (3 out of 12 patents)

10.  Laszlo Lazar (3 out of 4 patents)

11.  Istvan Szatmari (3 out of 3 patents)

12.  Ferenc Miklos (3 out of 3 patents)

13.  Lorand Kiss (3 out of 3 patents)

14.  Marta Palko (3 out of 3 patents)

15.  Ulf Lindahl (3 out of 6 patents)


Core Competencies:
Alzheimer's Disease
Parkinson's Disease
VAP-1 Inhibitors
Benzothiazole Derivatives
Pyridazinone Compounds
Metabolic Syndrome
7-Azaindoles
Anti-VAP-1 Antibodies
Inflammatory Conditions
Cellular Differentiation
Copper-Containing Amine Oxidases
Integrin Binding Peptide

28 patents:

1. 10973784 - Compositions and methods for treating Alzheimer's disease and Parkinson's disease (2021-04-13),
2. 10653699 - Controlled-release tozadenant formulations (2020-05-19),
3. 10576148 - Use of VAP-1 inhibitors for treating fibrotic conditions (2020-03-03),
4. 10561638 - Methods for treating dependence (2020-02-18),
5. 10479771 - Pyridazinone and pyridone compounds (2019-11-19),
6. 10314798 - Compositions and methods for treating Alzheimer's disease and Parkinson's disease (2019-06-11),
7. 9815795 - Pyridazinone and pyridone compounds (2017-11-14),
8. 9795671 - Use of VAP-1 inhibitors for treating fibrotic conditions (2017-10-24),
9. 9371290 - Pyridazinone compounds (2016-06-21),
10. 8735576 - Benzothiazole derivatives (2014-05-27),
11. 8501938 - Benzothiazole derivatives (2013-08-06),
12. 8212044 - Benzothiazole derivatives (2012-07-03),
13. 8168785 - Benzothiazole derivatives (2012-05-01),
14. 8142783 - Methods of treating an inflammatory condition involving VAP-1-mediated adhesion with VAP-1-specific antibodies (2012-03-27),
15. 8119651 - Compositions useful especially for treatment or prevention of metabolic syndrome (2012-02-21),
Company Overview
Biotie Therapies Corporation is a biopharmaceutical company based in Turku, Finland, focused on developing innovative therapies for neurological and psychiatric disorders. The company specializes in advancing treatments for conditions such as Parkinson's disease and addiction, leveraging its expertise in drug development and clinical research. Biotie's commitment to improving patient outcomes is reflected in its strategic collaborations and dedication to scientific excellence in the biopharmaceutical sector.
Profile summary synthesized from public USPTO records and patent filings.

logo

Company Badge

USPTO Data Jan 1 1976 - Oct 20 2026

Biotie Therapies Corporation USPTO Patent Assignee Logo
28 Patents

#6 in Turku

#128 in Finland

#23,299 in the World

Turku, FI
Turku, Finland

Biotie Therapies Corporation

Forward Citations = 44

66 inventors:

goldMedal David Smith (10 out of 10 patents)

silverMedal Markku Jalkanen (7 out of 16 patents)

bronzeMedal Thomas R Malefyt (7 out of 21 patents)

4.  Marjo Pihlavisto (7 out of 8 patents)

5.  Zsolt Szakonyi (5 out of 6 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Biotie Therapies Corporation. Retrieved from https://idiyas.com/company/biotie-therapies

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…